Clinical Trial

Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation

Study acronym: VIREAMIND
Recruiting
View on ClinicalTrials.gov →
Summary
Investigators seek to propose a non-drug therapeutic alternative, namely a mindfulness meditation protocol based on virtual reality training in order to induce progressive modifications of various indicators of craving. The study hypothesis is that the practice of mindfulness meditation in a virtual reality environment reduces the craving induced by cues and stress and therefore ultimately smoking relapse. The main objective of the protocol will be to demonstrate that mindfulness meditation can reduce long-term relapse (continuous cessation (\> 30 days) of smoking cessation). The participants will be randomized into two groups: the experimental group will perform six virtual reality sessions in a multisensory cabin at the rate of one session per week; the control group will be prescribed the gold standard treatment (nicotine patches and chewing gum). Participants will be seen again at three and six months to assess whether or not there has been a smoking relapse.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-03-10; most recent amendment 2026-01-12.
Status change: Not Yet Recruiting → Recruiting 2023-08-18
Trial Details
NCT Number NCT05766553
Lead Sponsor Centre Hospitalier Henri Laborit
Conditions Tobacco Use Disorder
Enrollment 200 participants
Start Date 2023-06-15
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-13